Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07465796) titled 'A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed Glioma' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Device Feasibility. Masking: None (Open Label).
Primary Sponsor: Coherence Neuro Australia Pty Limited
Condition:
Glioma
Tumor
Electrocorticography
Brain
Intervention:
Device: Electrocorticography for neural recording
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 2026
Target Sample Size: 10
Countries of Recruitment:
Australia
To know more,...